Is Quantrx Biomedical Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Quantrx Biomedical Corp (QTXB) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Quantrx Biomedical Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Quantrx Biomedical Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Quantrx Biomedical Corp?

Muslim investors may consider investing in Quantrx Biomedical Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Quantrx Biomedical Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Quantrx Biomedical Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Quantrx Biomedical Corp updated?

The Shariah compliance status of Quantrx Biomedical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Quantrx Biomedical Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Quantrx Biomedical Corp?

You can check the latest Shariah compliance status of Quantrx Biomedical Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Quantrx Biomedical Corp. Stock Analysis QTXB

United States Health Care Nano Cap

QuantRx Biomedical Corporation has developed its patented miniform pads and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs (the OTC Business). The Company is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents (the Diagnostics Business). The Company's platforms include inSync, Unique and original equipment manufacturer (OEM) branded over-the-counter and laboratory testing products based on its core intellectual property related to the Company PAD technology. Its OTC Business includes commercialization of its InSync feminine hygienic interlabial pad, the Unique Miniform for hemorrhoid application, and other treated miniforms, as well as maintaining established and continuing licensing relationships related to the OTC Business. It also owns certain diagnostic testing technology that is based on its lateral flow patents.

Key Statistics of Quantrx Biomedical Corp (QTXB)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

1.22M

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

78.70

Avg. Volume

202.87K

Dividend Yield

Financial Metrics & Statements of Quantrx Biomedical Corp (QTXB)

FAQ's for Quantrx Biomedical Corp (QTXB)

According to Musaffa’s Shariah screening methodology, Quantrx Biomedical Corp (QTXB) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.